Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phoebe Rich

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Immunotherapy|May 8, 2023
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summaryBruce Strober, Diamant Thaçi, Howard Sofen, et al.
Journal of the American Academy of Dermatology|May 23, 2026
Maintenance of Response With Icotrokinra, a Targeted Oral Peptide, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Randomized Treatment Withdrawal in Adults From the Phase 3, ICONIC-LEAD StudyJennifer Soung, Yong Cui, Robert Bissonnette, et al.
Journal of the American Academy of Dermatology|May 4, 2024
A tribute to Dr Robert Baran: The grandfather of European onychologyMark Holzberg, Boni Elewski, Carlton Ralph Daniel, et al.
Journal of the American Academy of Dermatology|September 17, 2022
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trialBruce Strober, Diamant Thaçi, Howard Sofen, et al.
Journal of the American Academy of Dermatology|March 1, 2020
Isolated nail lichen planus: An expert consensus on treatment of the classical formMatilde Iorizzo, Antonella Tosti, Michela Starace, et al.
International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.
Anais Brasileiros De Dermatologia|June 7, 2013
Consensus on melanonychia nail plate dermoscopyNilton Di Di Chiacchio, Débora Cadore de Farias, Bianca Maria Piraccini, et al.
Journal of the American Academy of Dermatology|February 8, 2019
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensusDimitrios Rigopoulos, Robert Baran, Soumiya Chiheb, et al.
Journal of Drugs in Dermatology : JDD|September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical TrialsAngela Moore, Lawrence J Green, Suzanne Bruce, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Modern definitions of periungual pigmentation (Hutchinson sign): Results of an expert opinion consensus conferenceEckart Haneke, Adam I Rubin, Marcel Pasch, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Immunotherapy|May 8, 2023
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summaryBruce Strober, Diamant Thaçi, Howard Sofen, et al.
Journal of the American Academy of Dermatology|May 23, 2026
Maintenance of Response With Icotrokinra, a Targeted Oral Peptide, for the Treatment of Moderate-to-Severe Plaque Psoriasis: Randomized Treatment Withdrawal in Adults From the Phase 3, ICONIC-LEAD StudyJennifer Soung, Yong Cui, Robert Bissonnette, et al.
Journal of the American Academy of Dermatology|May 4, 2024
A tribute to Dr Robert Baran: The grandfather of European onychologyMark Holzberg, Boni Elewski, Carlton Ralph Daniel, et al.
Journal of the American Academy of Dermatology|September 17, 2022
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trialBruce Strober, Diamant Thaçi, Howard Sofen, et al.
Journal of the American Academy of Dermatology|March 1, 2020
Isolated nail lichen planus: An expert consensus on treatment of the classical formMatilde Iorizzo, Antonella Tosti, Michela Starace, et al.
International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.
Anais Brasileiros De Dermatologia|June 7, 2013
Consensus on melanonychia nail plate dermoscopyNilton Di Di Chiacchio, Débora Cadore de Farias, Bianca Maria Piraccini, et al.
Journal of the American Academy of Dermatology|February 8, 2019
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensusDimitrios Rigopoulos, Robert Baran, Soumiya Chiheb, et al.
Journal of Drugs in Dermatology : JDD|September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical TrialsAngela Moore, Lawrence J Green, Suzanne Bruce, et al.
Journal of the American Academy of Dermatology|October 12, 2025
Modern definitions of periungual pigmentation (Hutchinson sign): Results of an expert opinion consensus conferenceEckart Haneke, Adam I Rubin, Marcel Pasch, et al.
Pageof 9